TheraCryf confident as loss narrows but posts no revenue for 2025
(Alliance News) - TheraCryf PLC on Tuesday reported it was in a good position despite "difficult markets" after narrowing its full-year loss. Read More
Price | 0.26p on 01-07-2025 | at 14:31:52
---|---|
Change | 0.00p 0% |
Buy | 0.28p |
Sell | 0.24p |
Buy / Sell TCF Shares |
Last Trade: | Sell 500,000.00 at 0.2428p |
Day's Volume: | 500,000 |
Last Close: | 0.26p |
Open: | 0.26p |
ISIN: | GB00BSVYN304 |
Day's Range | 0.26p - 0.26p |
52wk Range: | 0.204p - 1.22p |
Market Capitalisation: | £6m |
VWAP: | 0.2428p |
Shares in Issue: | 2,130m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 500,000 | 0.2428p | Ordinary |
08:07:01 - 01-Jul-25 |
Sell* | 24,803 | 0.254p | Ordinary |
16:29:51 - 30-Jun-25 |
Buy* | 357 | 0.28p | Ordinary |
16:11:01 - 30-Jun-25 |
Sell* | 400 | 0.2428p | Ordinary |
16:10:31 - 30-Jun-25 |
Buy* | 3,571 | 0.28p | SI Trade |
09:57:35 - 30-Jun-25 |
Sell* | 2,929 | 0.24p | SI Trade |
09:57:35 - 30-Jun-25 |
Buy* | 357 | 0.28p | SI Trade |
09:57:35 - 30-Jun-25 |
Sell* | 466 | 0.24p | SI Trade |
09:57:35 - 30-Jun-25 |
Sell* | 3,240 | 0.24p | SI Trade |
09:57:35 - 30-Jun-25 |
Buy* | 3,571 | 0.28p | SI Trade |
09:57:35 - 30-Jun-25 |
Theracryf PLC (TCF) Regulatory News |
||
Date | Source | Headline |
---|---|---|
16th Jun 2025 4:10 pm | RNS | Notice of AGM |
13th Jun 2025 7:00 am | RNS | Change of Adviser |
10th Jun 2025 12:32 pm | RNS-R | Ox-1 Investor Presentation |
3rd Jun 2025 7:00 am | RNS | Final results for year to 31 March 2025 |
23rd May 2025 7:14 am | RNS | Notice of Results and Ox-1 presentation |
22nd May 2025 12:43 pm | RNS | Holding(s) in Company |
22nd May 2025 12:22 pm | RNS | Director/PDMR Shareholding |
16th May 2025 1:00 pm | RNS | Holding(s) in Company |
12th May 2025 7:00 am | RNS | Master Service Agreement signed for Ox-1 programme |
1st May 2025 7:00 am | RNS | Board Appointment, Grant of Options, PDMR Dealing |